IGF‐I attenuates FFA‐induced activation of JNK1 phosphorylation and TNFα expression in human subcutaneous preadipocytes

Objective Free fatty acids (FFAs) are increased in visceral fat and contribute to insulin resistance through multiple mechanisms, including c‐Jun N‐terminal kinase (JNK) activation and expression of TNFα. Given that insulin‐like growth factor‐1 (IGF‐1)‐mediated proliferation is impaired in omental c...

Full description

Saved in:
Bibliographic Details
Published inObesity (Silver Spring, Md.) Vol. 21; no. 9; pp. 1843 - 1849
Main Authors Neacsu, Otilia, Cleveland, Kelly, Xu, Haiyan, Tchkonia, Tamara T., Kirkland, James L., Boney, Charlotte M.
Format Journal Article
LanguageEnglish
Published United States 01.09.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective Free fatty acids (FFAs) are increased in visceral fat and contribute to insulin resistance through multiple mechanisms, including c‐Jun N‐terminal kinase (JNK) activation and expression of TNFα. Given that insulin‐like growth factor‐1 (IGF‐1)‐mediated proliferation is impaired in omental compared to subcutaneous (SC) preadipocytes, we investigated IGF‐I anti‐inflammatory action in preadipocytes from SC and omental adipose tissue. Design and Methods Preadipocytes isolated from abdominal SC and omental fat of obese subjects were studied in primary culture. Cells were exposed to FFAs with or without IGF‐I pretreatment followed by analysis of cytokine expression and JNK phosphorylation. Lentivirus infection was used to express a constitutively active AKT (myr‐AKT) in omental preadipocytes. Results FFAs increased the expression of tumor necrosis factor (TNF)α, interleukin (IL)‐6, and monocyte chemotactic protein (MCP)‐1 in SC and omental preadipocytes. IGF‐I pretreatment reduced FFA‐induced JNK1 phosphorylation and TNFα expression in SC but not omental preadipocytes. Treatment with the JNK1/2 inhibitor SP600125 reduced FFA‐induced expression of TNFα. FFAs and MALP‐2, a specific TLR2/6 ligand, but not specific ligands for TLR4 and TLR1/2, increased JNK1 phosphorylation. IGF‐I completely inhibited MALP‐2‐stimulated phosphorylation of JNK1. Expression of myr‐AKT in omental preadipocytes inhibited FFA‐stimulated JNK1 phosphorylation. Conclusions IGF‐I attenuated FFA‐induced JNK1 phosphorylation and TNFα expression through activation of AKT in human subcutaneous but not omental preadipocytes.
AbstractList Objective Free fatty acids (FFAs) are increased in visceral fat and contribute to insulin resistance through multiple mechanisms, including c‐Jun N‐terminal kinase (JNK) activation and expression of TNFα. Given that insulin‐like growth factor‐1 (IGF‐1)‐mediated proliferation is impaired in omental compared to subcutaneous (SC) preadipocytes, we investigated IGF‐I anti‐inflammatory action in preadipocytes from SC and omental adipose tissue. Design and Methods Preadipocytes isolated from abdominal SC and omental fat of obese subjects were studied in primary culture. Cells were exposed to FFAs with or without IGF‐I pretreatment followed by analysis of cytokine expression and JNK phosphorylation. Lentivirus infection was used to express a constitutively active AKT (myr‐AKT) in omental preadipocytes. Results FFAs increased the expression of tumor necrosis factor (TNF)α, interleukin (IL)‐6, and monocyte chemotactic protein (MCP)‐1 in SC and omental preadipocytes. IGF‐I pretreatment reduced FFA‐induced JNK1 phosphorylation and TNFα expression in SC but not omental preadipocytes. Treatment with the JNK1/2 inhibitor SP600125 reduced FFA‐induced expression of TNFα. FFAs and MALP‐2, a specific TLR2/6 ligand, but not specific ligands for TLR4 and TLR1/2, increased JNK1 phosphorylation. IGF‐I completely inhibited MALP‐2‐stimulated phosphorylation of JNK1. Expression of myr‐AKT in omental preadipocytes inhibited FFA‐stimulated JNK1 phosphorylation. Conclusions IGF‐I attenuated FFA‐induced JNK1 phosphorylation and TNFα expression through activation of AKT in human subcutaneous but not omental preadipocytes.
Free fatty acids (FFAs) are increased in visceral fat and contribute to insulin resistance through multiple mechanisms, including c-Jun N-terminal kinase (JNK) activation and expression of TNFα. Given that insulin-like growth factor-1 (IGF-1)-mediated proliferation is impaired in omental compared to subcutaneous (SC) preadipocytes, we investigated IGF-I anti-inflammatory action in preadipocytes from SC and omental adipose tissue.OBJECTIVEFree fatty acids (FFAs) are increased in visceral fat and contribute to insulin resistance through multiple mechanisms, including c-Jun N-terminal kinase (JNK) activation and expression of TNFα. Given that insulin-like growth factor-1 (IGF-1)-mediated proliferation is impaired in omental compared to subcutaneous (SC) preadipocytes, we investigated IGF-I anti-inflammatory action in preadipocytes from SC and omental adipose tissue.Preadipocytes isolated from abdominal SC and omental fat of obese subjects were studied in primary culture. Cells were exposed to FFAs with or without IGF-I pretreatment followed by analysis of cytokine expression and JNK phosphorylation. Lentivirus infection was used to express a constitutively active AKT (myr-AKT) in omental preadipocytes.DESIGN AND METHODSPreadipocytes isolated from abdominal SC and omental fat of obese subjects were studied in primary culture. Cells were exposed to FFAs with or without IGF-I pretreatment followed by analysis of cytokine expression and JNK phosphorylation. Lentivirus infection was used to express a constitutively active AKT (myr-AKT) in omental preadipocytes.FFAs increased the expression of tumor necrosis factor (TNF)α, interleukin (IL)-6, and monocyte chemotactic protein (MCP)-1 in SC and omental preadipocytes. IGF-I pretreatment reduced FFA-induced JNK1 phosphorylation and TNFα expression in SC but not omental preadipocytes. Treatment with the JNK1/2 inhibitor SP600125 reduced FFA-induced expression of TNFα. FFAs and MALP-2, a specific TLR2/6 ligand, but not specific ligands for TLR4 and TLR1/2, increased JNK1 phosphorylation. IGF-I completely inhibited MALP-2-stimulated phosphorylation of JNK1. Expression of myr-AKT in omental preadipocytes inhibited FFA-stimulated JNK1 phosphorylation.RESULTSFFAs increased the expression of tumor necrosis factor (TNF)α, interleukin (IL)-6, and monocyte chemotactic protein (MCP)-1 in SC and omental preadipocytes. IGF-I pretreatment reduced FFA-induced JNK1 phosphorylation and TNFα expression in SC but not omental preadipocytes. Treatment with the JNK1/2 inhibitor SP600125 reduced FFA-induced expression of TNFα. FFAs and MALP-2, a specific TLR2/6 ligand, but not specific ligands for TLR4 and TLR1/2, increased JNK1 phosphorylation. IGF-I completely inhibited MALP-2-stimulated phosphorylation of JNK1. Expression of myr-AKT in omental preadipocytes inhibited FFA-stimulated JNK1 phosphorylation.IGF-I attenuated FFA-induced JNK1 phosphorylation and TNFα expression through activation of AKT in human subcutaneous but not omental preadipocytes.CONCLUSIONSIGF-I attenuated FFA-induced JNK1 phosphorylation and TNFα expression through activation of AKT in human subcutaneous but not omental preadipocytes.
Free fatty acids (FFAs) are increased in visceral fat and contribute to insulin resistance through multiple mechanisms, including c-Jun N-terminal kinase (JNK) activation and expression of TNFα. Given that insulin-like growth factor-1 (IGF-1)-mediated proliferation is impaired in omental compared to subcutaneous (SC) preadipocytes, we investigated IGF-I anti-inflammatory action in preadipocytes from SC and omental adipose tissue. Preadipocytes isolated from abdominal SC and omental fat of obese subjects were studied in primary culture. Cells were exposed to FFAs with or without IGF-I pretreatment followed by analysis of cytokine expression and JNK phosphorylation. Lentivirus infection was used to express a constitutively active AKT (myr-AKT) in omental preadipocytes. FFAs increased the expression of tumor necrosis factor (TNF)α, interleukin (IL)-6, and monocyte chemotactic protein (MCP)-1 in SC and omental preadipocytes. IGF-I pretreatment reduced FFA-induced JNK1 phosphorylation and TNFα expression in SC but not omental preadipocytes. Treatment with the JNK1/2 inhibitor SP600125 reduced FFA-induced expression of TNFα. FFAs and MALP-2, a specific TLR2/6 ligand, but not specific ligands for TLR4 and TLR1/2, increased JNK1 phosphorylation. IGF-I completely inhibited MALP-2-stimulated phosphorylation of JNK1. Expression of myr-AKT in omental preadipocytes inhibited FFA-stimulated JNK1 phosphorylation. IGF-I attenuated FFA-induced JNK1 phosphorylation and TNFα expression through activation of AKT in human subcutaneous but not omental preadipocytes.
Author Tchkonia, Tamara T.
Boney, Charlotte M.
Xu, Haiyan
Kirkland, James L.
Cleveland, Kelly
Neacsu, Otilia
AuthorAffiliation 3 Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester MN, 55905
1 Department of Pediatrics, Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence RI, 02903
2 Department of Medicine, Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence RI, 02903
AuthorAffiliation_xml – name: 1 Department of Pediatrics, Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence RI, 02903
– name: 3 Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester MN, 55905
– name: 2 Department of Medicine, Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence RI, 02903
Author_xml – sequence: 1
  givenname: Otilia
  surname: Neacsu
  fullname: Neacsu, Otilia
  organization: Rhode Island Hospital and Warren Alpert Medical School of Brown University
– sequence: 2
  givenname: Kelly
  surname: Cleveland
  fullname: Cleveland, Kelly
  organization: Rhode Island Hospital and Warren Alpert Medical School of Brown University
– sequence: 3
  givenname: Haiyan
  surname: Xu
  fullname: Xu, Haiyan
  organization: Rhode Island Hospital and Warren Alpert Medical School of Brown University
– sequence: 4
  givenname: Tamara T.
  surname: Tchkonia
  fullname: Tchkonia, Tamara T.
  organization: Robert and Arlene Kogod Center on Aging, Mayo Clinic
– sequence: 5
  givenname: James L.
  surname: Kirkland
  fullname: Kirkland, James L.
  organization: Robert and Arlene Kogod Center on Aging, Mayo Clinic
– sequence: 6
  givenname: Charlotte M.
  surname: Boney
  fullname: Boney, Charlotte M.
  organization: Rhode Island Hospital and Warren Alpert Medical School of Brown University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23512893$$D View this record in MEDLINE/PubMed
BookMark eNp9Uctu1DAUtVAr-oAFP4C8hMW0dmzHkw1SqUiZtmo3RYKV5dg3jFHGDrFTiNRFP4Ff4Uf4CL6ETNOOAAkWlq1zzz3n-p49tOWDB4SeUXJACckOQzUcZIRlxSO0SwtGZpIV77c27zndQXsxfiKE50TQx2gnY4Jm84LtopvFSfnz9tsC65TA9zpBxGV5NELO296Axdokd62TCx6HGp9enFHcLkMcTzc0E669xVcX5Y_vGL62HcS4Bp3Hy36lPY59ZfqkPYQ-4rGsrWuDGUanJ2i71k2Ep_f3PnpXvrk6fjs7vzxZHB-dzwynopjNjQRjiLVGUFkQCUILAC6tzWte1ZnmXHJCrLSMGSOJyAWrmM2p4YLXtmb76NWk2_bVCqwBnzrdqLZzK90NKmin_qx4t1Qfw7VieUGoyEeBF_cCXfjcQ0xq5aKBppl-pShncyElk2vq89-9NiYPKx8JLyeC6UKMHdQbCiVqHaca41R3cY7cw7-4xqW7nY9juuZ_HV9cA8O_pdXl6w9Txy_KU7a0
CitedBy_id crossref_primary_10_1080_08830185_2019_1645138
crossref_primary_10_1039_C4FO01153H
crossref_primary_10_33549_physiolres_933244
crossref_primary_10_1371_journal_pone_0099382
crossref_primary_10_3390_cells10071738
crossref_primary_10_1002_oby_21372
crossref_primary_10_1177_1934578X20918418
crossref_primary_10_3390_molecules23123245
crossref_primary_10_1016_j_ejogrb_2015_09_013
crossref_primary_10_3389_fcimb_2018_00151
crossref_primary_10_1016_j_bbadis_2018_08_020
crossref_primary_10_3390_biomedicines10081953
crossref_primary_10_1016_j_jfda_2016_10_011
crossref_primary_10_3892_mmr_2017_7710
Cites_doi 10.1002/1097-4547(20001215)62:6<799::AID-JNR6>3.0.CO;2-1
10.1210/en.2006-0536
10.1074/jbc.271.49.31372
10.1016/j.bcp.2005.02.009
10.1007/s10495-010-0547-z
10.1196/annals.1326.021
10.1016/j.molimm.2009.04.008
10.1152/ajpendo.2001.280.2.E238
10.1210/jc.83.3.847
10.1210/en.2010-0043
10.1074/jbc.M504611200
10.1161/ATVBAHA.107.156257
10.1093/jn/134.10.2673
10.1096/fasebj.13.2.305
10.1042/BJ20041140
10.1074/jbc.M210811200
10.1074/jbc.273.40.25961
10.2337/db11-1753
10.2337/db06-0540
10.1172/JCI200319451
10.2353/ajpath.2007.060699
10.1210/en.2004-0488
10.1172/JCI25102
10.1038/oby.2008.25
10.1038/oby.2008.607
10.1016/S0083-6729(06)74018-3
10.1093/jn/135.8.1841
10.3132/dvdr.2006.003
10.1152/ajpendo.00202.2006
10.1074/jbc.M312990200
10.1152/ajpendo.00523.2006
10.1016/S0896-6273(02)00821-8
10.1038/nature05487
10.1016/j.bbrc.2008.01.035
10.1152/ajpregu.00653.2001
10.1152/ajpendo.00265.2004
10.1101/gad.1216504
10.1210/en.2009-1140
10.2337/db09-0942
ContentType Journal Article
Copyright Copyright © 2013 The Obesity Society
Copyright © 2013 The Obesity Society.
Copyright_xml – notice: Copyright © 2013 The Obesity Society
– notice: Copyright © 2013 The Obesity Society.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1002/oby.20329
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1930-739X
EndPage 1849
ExternalDocumentID PMC3690156
23512893
10_1002_oby_20329
OBY20329
Genre article
Comparative Study
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIDDK NIH HHS
  grantid: R01DK59339
– fundername: NIA NIH HHS
  grantid: P01AG031736
– fundername: NIDDK NIH HHS
  grantid: R01DK080746
– fundername: NIA NIH HHS
  grantid: P01 AG031736
– fundername: NIDDK NIH HHS
  grantid: R01 DK059339
– fundername: NIA NIH HHS
  grantid: R01 AG013925
– fundername: NIDDK NIH HHS
  grantid: R01 DK080746
– fundername: NIA NIH HHS
  grantid: R01AG13925
GroupedDBID ---
05W
0R~
123
1OC
24P
29N
2FS
2WC
31~
33P
39C
3SF
3V.
4.4
50Y
52U
52V
53G
70F
7X7
8-1
8C1
A00
AAESR
AAEVG
AAFWJ
AAHBH
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCUV
ABIVO
ABJNI
ABLJU
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFKRA
AFPWT
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZQEC
AZVAB
BAWUL
BENPR
BFHJK
BHBCM
BKNYI
BMXJE
BOGZA
BPHCQ
BRXPI
BVXVI
CS3
DCZOG
DIK
DPXWK
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
EMOBN
F5P
FUBAC
FYUFA
G-S
GODZA
HGLYW
HZ~
KBYEO
LATKE
LEEKS
LH4
LITHE
LOXES
LUTES
LW6
LYRES
M0R
M1P
MEWTI
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY~
O66
O9-
OK1
P2W
PQQKQ
PROAC
PSQYO
R.K
ROL
SUPJJ
UKHRP
WBKPD
WHG
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOQ
WQJ
WVDHM
WXSBR
WYJ
YHZ
AAYXX
AEYWJ
AGHNM
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c4159-8c7ecc0ddc517907e5a5ee47dd6f4bf2a447400d7d33cc705653b3d61c454fdf3
ISSN 1930-7381
1930-739X
IngestDate Thu Aug 21 18:09:12 EDT 2025
Thu Jul 10 17:53:20 EDT 2025
Mon Jul 21 06:05:55 EDT 2025
Thu Apr 24 23:11:41 EDT 2025
Tue Jul 01 01:16:10 EDT 2025
Wed Jan 22 16:41:14 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
License Copyright © 2013 The Obesity Society.
Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4159-8c7ecc0ddc517907e5a5ee47dd6f4bf2a447400d7d33cc705653b3d61c454fdf3
Notes O. Neacsu and K. Cleveland contributed equally to the work.
Disclosure: The authors declare no conflict of interest.
Funding agencies: This research was supported in part by NIH RO1DK59339 (C.M.B.), Rhode Island Hospital Department of Pediatrics (C.M.B.), NIH R01DK080746 (H.X.), NIH R01AG13925 and NIH P01AG031736 (J.L.K.), the Noaber Foundation (J.L.K.), and the Ted Nash Foundation (J.L.K.).
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
contributed equally to the work
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC3690156
PMID 23512893
PQID 1438577376
PQPubID 23479
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3690156
proquest_miscellaneous_1438577376
pubmed_primary_23512893
crossref_primary_10_1002_oby_20329
crossref_citationtrail_10_1002_oby_20329
wiley_primary_10_1002_oby_20329_OBY20329
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate September 2013
PublicationDateYYYYMMDD 2013-09-01
PublicationDate_xml – month: 09
  year: 2013
  text: September 2013
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Obesity (Silver Spring, Md.)
PublicationTitleAlternate Obesity (Silver Spring)
PublicationYear 2013
References 2012; 61
2004; 145
2009; 46
2006; 74
2010; 59
2010; 15
2010
2001; 280
2005; 135
2006; 55
2005; 115
2002; 35
2008; 16
2006; 3
2008; 368
1998; 83
2003; 278
2003; 112
1998; 273
2005; 69
2004; 134
2005; 280
2002; 282
2004; 279
2007; 293
2005; 385
2004; 18
2005; 288
2007; 170
2007; 292
1999; 13
1996; 271
2000; 62
2010; 151
2006; 444
2006; 1072
2006; 147
2009; 17
2007; 27
e_1_2_5_27_1
e_1_2_5_28_1
e_1_2_5_25_1
e_1_2_5_26_1
e_1_2_5_23_1
e_1_2_5_24_1
e_1_2_5_21_1
e_1_2_5_22_1
e_1_2_5_29_1
e_1_2_5_20_1
e_1_2_5_41_1
e_1_2_5_40_1
e_1_2_5_15_1
e_1_2_5_38_1
e_1_2_5_14_1
e_1_2_5_39_1
e_1_2_5_17_1
e_1_2_5_36_1
e_1_2_5_9_1
e_1_2_5_16_1
e_1_2_5_37_1
e_1_2_5_11_1
e_1_2_5_34_1
e_1_2_5_7_1
e_1_2_5_10_1
e_1_2_5_35_1
e_1_2_5_6_1
e_1_2_5_13_1
e_1_2_5_32_1
e_1_2_5_5_1
e_1_2_5_12_1
e_1_2_5_33_1
e_1_2_5_4_1
e_1_2_5_3_1
e_1_2_5_2_1
e_1_2_5_19_1
e_1_2_5_18_1
Poulain‐Godefroy O (e_1_2_5_8_1) 2010
e_1_2_5_30_1
e_1_2_5_31_1
20555032 - Endocrinology. 2010 Aug;151(8):3752-63
15826602 - Biochem Pharmacol. 2005 May 1;69(9):1315-24
15242986 - Endocrinology. 2004 Oct;145(10):4522-31
18201559 - Biochem Biophys Res Commun. 2008 Mar 28;368(1):81-7
8940145 - J Biol Chem. 1996 Dec 6;271(49):31372-8
15456405 - Biochem J. 2005 Jan 15;385(Pt 2):399-408
15864338 - J Clin Invest. 2005 May;115(5):1111-9
14966134 - J Biol Chem. 2004 Apr 23;279(17):16971-9
17027526 - Vitam Horm. 2006;74:443-77
19477016 - Mol Immunol. 2009 Jul;46(11-12):2256-66
17057223 - Ann N Y Acad Sci. 2006 Aug;1072:407-9
19148127 - Obesity (Silver Spring). 2009 Apr;17(4):648-56
16784178 - Diab Vasc Dis Res. 2006 May;3(1):26-33
16873530 - Endocrinology. 2006 Nov;147(11):5340-51
9973318 - FASEB J. 1999 Feb;13(2):305-12
22596050 - Diabetes. 2012 Jul;61(7):1691-9
16936206 - Diabetes. 2006 Sep;55(9):2571-8
11107164 - J Neurosci Res. 2000 Dec 15;62(6):799-808
12194869 - Neuron. 2002 Aug 15;35(4):697-709
19846802 - Diabetes. 2010 Jan;59(1):105-9
20339530 - Mediators Inflamm. 2010;2010:823486
15383371 - Am J Physiol Endocrinol Metab. 2005 Jan;288(1):E267-77
17916769 - Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2684-90
15465765 - J Nutr. 2004 Oct;134(10):2673-7
16046706 - J Nutr. 2005 Aug;135(8):1841-6
16985259 - Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E298-307
9506738 - J Clin Endocrinol Metab. 1998 Mar;83(3):847-50
18292749 - Obesity (Silver Spring). 2008 May;16(5):932-7
20963499 - Apoptosis. 2010 Dec;15(12):1470-9
11959668 - Am J Physiol Regul Integr Comp Physiol. 2002 May;282(5):R1286-96
12519759 - J Biol Chem. 2003 Mar 14;278(11):9850-5
14679177 - J Clin Invest. 2003 Dec;112(12):1821-30
17167476 - Nature. 2006 Dec 14;444(7121):875-80
17519282 - Am J Physiol Endocrinol Metab. 2007 Aug;293(2):E576-86
9748273 - J Biol Chem. 1998 Oct 2;273(40):25961-6
20130114 - Endocrinology. 2010 Mar;151(3):1097-108
17525261 - Am J Pathol. 2007 Jun;170(6):1931-41
15314024 - Genes Dev. 2004 Aug 15;18(16):1976-80
16085647 - J Biol Chem. 2005 Oct 21;280(42):35361-71
11158926 - Am J Physiol Endocrinol Metab. 2001 Feb;280(2):E238-47
References_xml – volume: 16
  start-page: 932
  year: 2008
  end-page: 937
  article-title: Inducible Toll‐like receptor and NF‐kappaB regulatory pathway expression in human adipose tissue
  publication-title: Obesity (Silver Spring)
– volume: 385
  start-page: 399
  year: 2005
  end-page: 408
  article-title: Identification and characterization of pleckstrin‐homology‐domain‐dependent and isoenzyme‐specific Akt inhibitors
  publication-title: Biochem J
– volume: 46
  start-page: 2256
  year: 2009
  end-page: 2266
  article-title: Signaling pathways mediating beta3‐adrenergic receptor‐induced production of interleukin‐6 in adipocytes
  publication-title: Mol Immunol
– volume: 15
  start-page: 1470
  year: 2010
  end-page: 1479
  article-title: Insulin‐like growth factor 1 protects human neuroblastoma cells SH‐EP1 against MPP+‐induced apoptosis by AKT/GSK‐3beta/JNK signaling
  publication-title: Apoptosis
– volume: 444
  start-page: 875
  year: 2006
  end-page: 880
  article-title: Mechanisms linking obesity with cardiovascular disease
  publication-title: Nature
– volume: 59
  start-page: 105
  year: 2010
  end-page: 109
  article-title: Adipocyte turnover: relevance to human adipose tissue morphology
  publication-title: Diabetes
– volume: 61
  start-page: 1691
  year: 2012
  end-page: 1699
  article-title: Intrinsic differences in adipocyte precursor cells from different white fat depots
  publication-title: Diabetes
– volume: 27
  start-page: 2684
  year: 2007
  end-page: 2690
  article-title: IGF‐1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE‐deficient mice
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 151
  start-page: 3752
  year: 2010
  end-page: 3763
  article-title: IGF‐I activation of the AKT pathway is impaired in visceral but not subcutaneous preadipocytes from obese subjects
  publication-title: Endocrinology
– volume: 1072
  start-page: 407
  year: 2006
  end-page: 409
  article-title: Toll‐like receptor expression and response to specific stimulation in adipocytes and preadipocytes: on the role of fat in inflammation
  publication-title: Ann N Y Acad Sci
– volume: 292
  start-page: E298
  year: 2007
  end-page: E307
  article-title: Identification of depot‐specific human fat cell progenitors through distinct expression profiles and developmental gene patterns
  publication-title: Am J Physiol Endocrinol Metab
– volume: 83
  start-page: 847
  year: 1998
  end-page: 850
  article-title: Omental and subcutaneous adipose tissues of obese subjects release interleukin‐6: depot difference and regulation by glucocorticoid
  publication-title: J Clin Endocrinol Metab
– volume: 62
  start-page: 799
  year: 2000
  end-page: 808
  article-title: Akt negatively regulates the cJun N‐terminal kinase pathway in PC12 cells
  publication-title: J Neurosci Res
– volume: 55
  start-page: 2571
  year: 2006
  end-page: 2578
  article-title: Fat depot‐specific characteristics are retained in strains derived from single human preadipocytes
  publication-title: Diabetes
– volume: 282
  start-page: R1286
  year: 2002
  end-page: R1296
  article-title: Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes
  publication-title: Am J Physiol Regul Integr Comp Physiol
– volume: 288
  start-page: E267
  year: 2005
  end-page: E277
  article-title: Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots
  publication-title: Am J Physiol Endocrinol Metab
– volume: 147
  start-page: 5340
  year: 2006
  end-page: 5351
  article-title: Preadipocytes mediate lipopolysaccharide‐induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes
  publication-title: Endocrinology
– volume: 17
  start-page: 648
  year: 2009
  end-page: 656
  article-title: Innate immunity and adipocyte function: ligand‐specific activation of multiple Toll‐like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes
  publication-title: Obesity (Silver Spring)
– volume: 368
  start-page: 81
  year: 2008
  end-page: 87
  article-title: Low‐dose GH supplementation reduces the TLR2 and TNF‐alpha expressions in visceral fat
  publication-title: Biochem Biophys Res Commun
– volume: 134
  start-page: 2673
  year: 2004
  end-page: 2677
  article-title: Expression of interleukin‐6 is greater in preadipocytes than in adipocytes of 3T3‐L1 cells and C57BL/6J and ob/ob mice
  publication-title: J Nutr
– volume: 151
  start-page: 1097
  year: 2010
  end-page: 1108
  article-title: Toll‐like receptor ligands cause proinflammatory and prodiabetic activation of adipocytes via phosphorylation of extracellular signal‐regulated kinase and c‐Jun N‐terminal kinase but not interferon regulatory factor‐3
  publication-title: Endocrinology
– volume: 35
  start-page: 697
  year: 2002
  end-page: 709
  article-title: Akt1 regulates a JNK scaffold during excitotoxic apoptosis
  publication-title: Neuron
– volume: 279
  start-page: 16971
  year: 2004
  end-page: 16979
  article-title: Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll‐like receptor 2 dimerized with Toll‐like receptor 6 or 1
  publication-title: J Biol Chem
– volume: 74
  start-page: 443
  year: 2006
  end-page: 477
  article-title: Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells
  publication-title: Vitam Horm
– start-page: 823486
  year: 2010
  article-title: Inflammatory role of Toll‐like receptors in human and murine adipose tissue
  publication-title: Mediators Inflamm
– volume: 280
  start-page: E238
  year: 2001
  end-page: E247
  article-title: Fat depot origin affects fatty acid handling in cultured rat and human preadipocytes
  publication-title: Am J Physiol Endocrinol Metab
– volume: 170
  start-page: 1931
  year: 2007
  end-page: 1941
  article-title: Leptin‐dependent toll‐like receptor expression and responsiveness in preadipocytes and adipocytes
  publication-title: Am J Pathol
– volume: 3
  start-page: 26
  year: 2006
  end-page: 33
  article-title: TNF and TNF receptor expression and insulin sensitivity in human omental and subcutaneous adipose tissue—influence of BMI and adipose distribution
  publication-title: Diab Vasc Dis Res
– volume: 69
  start-page: 1315
  year: 2005
  end-page: 1324
  article-title: Involvement of multiple signaling pathways in the post‐bariatric induction of IL‐6 and IL‐8 mRNA and release in human visceral adipose tissue
  publication-title: Biochem Pharmacol
– volume: 293
  start-page: E576
  year: 2007
  end-page: E586
  article-title: Palmitate modulates intracellular signaling, induces endoplasmic reticulum stress, and causes apoptosis in mouse 3T3‐L1 and rat primary preadipocytes
  publication-title: Am J Physiol Endocrinol Metab
– volume: 135
  start-page: 1841
  year: 2005
  end-page: 1846
  article-title: Palmitate activates the NF‐kappaB transcription factor and induces IL‐6 and TNFalpha expression in 3T3‐L1 adipocytes
  publication-title: J Nutr
– volume: 13
  start-page: 305
  year: 1999
  end-page: 312
  article-title: A role for preadipocytes as macrophage‐like cells
  publication-title: FASEB J
– volume: 273
  start-page: 25961
  year: 1998
  end-page: 25966
  article-title: Insulin‐like growth factor‐I inhibits the stress‐activated protein kinase/c‐Jun N‐terminal kinase
  publication-title: J Biol Chem
– volume: 145
  start-page: 4522
  year: 2004
  end-page: 4531
  article-title: Cross‐talk between phosphatidylinositol 3‐kinase/AKT and c‐jun NH2‐terminal kinase mediates survival of isolated human islets
  publication-title: Endocrinology
– volume: 280
  start-page: 35361
  year: 2005
  end-page: 35371
  article-title: JNK and tumor necrosis factor‐alpha mediate free fatty acid‐induced insulin resistance in 3T3‐L1 adipocytes
  publication-title: J Biol Chem
– volume: 112
  start-page: 1821
  year: 2003
  end-page: 1830
  article-title: Chronic inflammation in fat plays a crucial role in the development of obesity‐related insulin resistance
  publication-title: J Clin Invest
– volume: 271
  start-page: 31372
  year: 1996
  end-page: 31378
  article-title: Expression of a constitutively active Akt Ser/Thr kinase in 3T3‐L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation
  publication-title: J Biol Chem
– volume: 18
  start-page: 1976
  year: 2004
  end-page: 1980
  article-title: An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue
  publication-title: Genes Dev
– volume: 278
  start-page: 9850
  year: 2003
  end-page: 9855
  article-title: Preadipocyte conversion to macrophage. Evidence of plasticity
  publication-title: J Biol Chem
– volume: 115
  start-page: 1111
  year: 2005
  end-page: 1119
  article-title: Inflammation, stress, and diabetes
  publication-title: J Clin Invest
– ident: e_1_2_5_39_1
  doi: 10.1002/1097-4547(20001215)62:6<799::AID-JNR6>3.0.CO;2-1
– ident: e_1_2_5_22_1
  doi: 10.1210/en.2006-0536
– ident: e_1_2_5_29_1
  doi: 10.1074/jbc.271.49.31372
– ident: e_1_2_5_34_1
  doi: 10.1016/j.bcp.2005.02.009
– ident: e_1_2_5_38_1
  doi: 10.1007/s10495-010-0547-z
– ident: e_1_2_5_7_1
  doi: 10.1196/annals.1326.021
– ident: e_1_2_5_35_1
  doi: 10.1016/j.molimm.2009.04.008
– ident: e_1_2_5_18_1
  doi: 10.1152/ajpendo.2001.280.2.E238
– ident: e_1_2_5_30_1
  doi: 10.1210/jc.83.3.847
– ident: e_1_2_5_19_1
  doi: 10.1210/en.2010-0043
– ident: e_1_2_5_20_1
  doi: 10.1074/jbc.M504611200
– ident: e_1_2_5_36_1
  doi: 10.1161/ATVBAHA.107.156257
– ident: e_1_2_5_32_1
  doi: 10.1093/jn/134.10.2673
– ident: e_1_2_5_12_1
  doi: 10.1096/fasebj.13.2.305
– ident: e_1_2_5_28_1
  doi: 10.1042/BJ20041140
– ident: e_1_2_5_13_1
  doi: 10.1074/jbc.M210811200
– ident: e_1_2_5_27_1
  doi: 10.1074/jbc.273.40.25961
– ident: e_1_2_5_16_1
  doi: 10.2337/db11-1753
– ident: e_1_2_5_25_1
  doi: 10.2337/db06-0540
– ident: e_1_2_5_5_1
  doi: 10.1172/JCI200319451
– ident: e_1_2_5_26_1
  doi: 10.2353/ajpath.2007.060699
– ident: e_1_2_5_37_1
  doi: 10.1210/en.2004-0488
– ident: e_1_2_5_4_1
  doi: 10.1172/JCI25102
– ident: e_1_2_5_9_1
  doi: 10.1038/oby.2008.25
– ident: e_1_2_5_10_1
  doi: 10.1038/oby.2008.607
– ident: e_1_2_5_14_1
  doi: 10.1016/S0083-6729(06)74018-3
– ident: e_1_2_5_21_1
  doi: 10.1093/jn/135.8.1841
– ident: e_1_2_5_31_1
  doi: 10.3132/dvdr.2006.003
– ident: e_1_2_5_15_1
  doi: 10.1152/ajpendo.00202.2006
– ident: e_1_2_5_6_1
  doi: 10.1074/jbc.M312990200
– ident: e_1_2_5_23_1
  doi: 10.1152/ajpendo.00523.2006
– ident: e_1_2_5_40_1
  doi: 10.1016/S0896-6273(02)00821-8
– ident: e_1_2_5_2_1
  doi: 10.1038/nature05487
– start-page: 823486
  year: 2010
  ident: e_1_2_5_8_1
  article-title: Inflammatory role of Toll‐like receptors in human and murine adipose tissue
  publication-title: Mediators Inflamm
– ident: e_1_2_5_24_1
  doi: 10.1016/j.bbrc.2008.01.035
– ident: e_1_2_5_3_1
  doi: 10.1152/ajpregu.00653.2001
– ident: e_1_2_5_17_1
  doi: 10.1152/ajpendo.00265.2004
– ident: e_1_2_5_41_1
  doi: 10.1101/gad.1216504
– ident: e_1_2_5_33_1
  doi: 10.1210/en.2009-1140
– ident: e_1_2_5_11_1
  doi: 10.2337/db09-0942
– reference: 11107164 - J Neurosci Res. 2000 Dec 15;62(6):799-808
– reference: 15314024 - Genes Dev. 2004 Aug 15;18(16):1976-80
– reference: 12194869 - Neuron. 2002 Aug 15;35(4):697-709
– reference: 18201559 - Biochem Biophys Res Commun. 2008 Mar 28;368(1):81-7
– reference: 8940145 - J Biol Chem. 1996 Dec 6;271(49):31372-8
– reference: 20339530 - Mediators Inflamm. 2010;2010:823486
– reference: 9973318 - FASEB J. 1999 Feb;13(2):305-12
– reference: 22596050 - Diabetes. 2012 Jul;61(7):1691-9
– reference: 15864338 - J Clin Invest. 2005 May;115(5):1111-9
– reference: 12519759 - J Biol Chem. 2003 Mar 14;278(11):9850-5
– reference: 14679177 - J Clin Invest. 2003 Dec;112(12):1821-30
– reference: 14966134 - J Biol Chem. 2004 Apr 23;279(17):16971-9
– reference: 15383371 - Am J Physiol Endocrinol Metab. 2005 Jan;288(1):E267-77
– reference: 16985259 - Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E298-307
– reference: 17525261 - Am J Pathol. 2007 Jun;170(6):1931-41
– reference: 16085647 - J Biol Chem. 2005 Oct 21;280(42):35361-71
– reference: 20555032 - Endocrinology. 2010 Aug;151(8):3752-63
– reference: 19846802 - Diabetes. 2010 Jan;59(1):105-9
– reference: 20130114 - Endocrinology. 2010 Mar;151(3):1097-108
– reference: 15456405 - Biochem J. 2005 Jan 15;385(Pt 2):399-408
– reference: 17027526 - Vitam Horm. 2006;74:443-77
– reference: 11959668 - Am J Physiol Regul Integr Comp Physiol. 2002 May;282(5):R1286-96
– reference: 15826602 - Biochem Pharmacol. 2005 May 1;69(9):1315-24
– reference: 17916769 - Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2684-90
– reference: 18292749 - Obesity (Silver Spring). 2008 May;16(5):932-7
– reference: 16936206 - Diabetes. 2006 Sep;55(9):2571-8
– reference: 20963499 - Apoptosis. 2010 Dec;15(12):1470-9
– reference: 17057223 - Ann N Y Acad Sci. 2006 Aug;1072:407-9
– reference: 9506738 - J Clin Endocrinol Metab. 1998 Mar;83(3):847-50
– reference: 17519282 - Am J Physiol Endocrinol Metab. 2007 Aug;293(2):E576-86
– reference: 15242986 - Endocrinology. 2004 Oct;145(10):4522-31
– reference: 9748273 - J Biol Chem. 1998 Oct 2;273(40):25961-6
– reference: 16046706 - J Nutr. 2005 Aug;135(8):1841-6
– reference: 16784178 - Diab Vasc Dis Res. 2006 May;3(1):26-33
– reference: 17167476 - Nature. 2006 Dec 14;444(7121):875-80
– reference: 19148127 - Obesity (Silver Spring). 2009 Apr;17(4):648-56
– reference: 15465765 - J Nutr. 2004 Oct;134(10):2673-7
– reference: 16873530 - Endocrinology. 2006 Nov;147(11):5340-51
– reference: 11158926 - Am J Physiol Endocrinol Metab. 2001 Feb;280(2):E238-47
– reference: 19477016 - Mol Immunol. 2009 Jul;46(11-12):2256-66
SSID ssj0046051
Score 2.1753209
Snippet Objective Free fatty acids (FFAs) are increased in visceral fat and contribute to insulin resistance through multiple mechanisms, including c‐Jun N‐terminal...
Free fatty acids (FFAs) are increased in visceral fat and contribute to insulin resistance through multiple mechanisms, including c-Jun N-terminal kinase (JNK)...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1843
SubjectTerms Adipocytes - drug effects
Adipocytes - metabolism
Adult
Anthracenes - pharmacology
Body Fat Distribution
Fatty Acids, Nonesterified - metabolism
Fatty Acids, Nonesterified - pharmacology
Female
Humans
Inflammation Mediators - metabolism
Insulin Resistance
Insulin-Like Growth Factor I - metabolism
Insulin-Like Growth Factor I - pharmacology
Intra-Abdominal Fat - drug effects
Intra-Abdominal Fat - metabolism
JNK Mitogen-Activated Protein Kinases - metabolism
Lipopeptides - metabolism
Male
Obesity - metabolism
Omentum
Phosphorylation
Proto-Oncogene Proteins c-akt - metabolism
Subcutaneous Fat, Abdominal - drug effects
Subcutaneous Fat, Abdominal - metabolism
Toll-Like Receptors - metabolism
Tumor Necrosis Factor-alpha - metabolism
Title IGF‐I attenuates FFA‐induced activation of JNK1 phosphorylation and TNFα expression in human subcutaneous preadipocytes
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Foby.20329
https://www.ncbi.nlm.nih.gov/pubmed/23512893
https://www.proquest.com/docview/1438577376
https://pubmed.ncbi.nlm.nih.gov/PMC3690156
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3djtJAFJ7gmhhvjP_iX0bjJpuQIu1MKb3c3SzCEtkLuwleNdOZaWiChQA1wXjhI_gqvoCP4EP4JJ6Z6R8LJqsXNDCdlpbzMec7M1_PQegNcVxGXZtZNqNdi_qEWyyOYstxooi4gnUdqQWy4-7gkp5P3Emj8bOmWsrWUZt_2ftcyf9YFdrAruop2X-wbHlSaID3YF_YgoVhey0bD9_1S7HCsKUyZaaZ4o6tfv-43AFBd6YW-dUTDJ9Lgng-HtmtxXS-gtdyYwRxeiEhGPcPT88OT2yV_N-IZLUY0hTzW2URz4BPSqWchd1MJIs536xzJWLOcvNqA4q9fkiU9Lpl5g_17Kto12YfxjAirzLVfrFOZklNNqTETLnociRnleh0onsPWLKpcB3wKfBcI_sN2Ce2ZK2gXZ_PULUl_GI-wwzBPulYHjGFXNqy3qaL7pbjtmPX8OnXBmFVwqbm0OGjv9dZmOSz82jTVmXk_cojFiqAK46ylC-aVM9OCIeG-tAb6KYDYYoO6YejggmoJWfbqBrMHRWZrTrO2_Jbt_nQTpCzq9Wtx1CaBAV30Z08esHHBor3UEOm99Gt97k-4wH6Coj8_e37EFdYxIBFaMpRiCsU4nmMFQrxFRRisDoGFP76gSsE4iTFGoG4jkC8hcCH6LJ_FpwOrLy-h8WBNvpWj3swgHSE4DpPnCdd5kpJPSG6MY1ih1HqgYsRniCEcw-ouksiIro2py6NRUweoYN0nsonCEvRgQPBWUasR10mIkIYAWfuMJsIIu0mOip-5ZDnye9VDZZZuGPLJnpddl2YjC_7Or0qTBXCeKwW2cyNQyhNeq6nLqWJHhvTladxCNBrCBCayNsyatlB5Xrf3pMmU53znajCcS6c80ib_-9XFl6cfNRvnl7nPp6h29V_8Dk6WC8z-QJY9jp6qaH8B7is1dg
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IGF%E2%80%90I+attenuates+FFA%E2%80%90induced+activation+of+JNK1+phosphorylation+and+TNF%CE%B1+expression+in+human+subcutaneous+preadipocytes&rft.jtitle=Obesity+%28Silver+Spring%2C+Md.%29&rft.au=Neacsu%2C+Otilia&rft.au=Cleveland%2C+Kelly&rft.au=Xu%2C+Haiyan&rft.au=Tchkonia%2C+Tamara+T.&rft.date=2013-09-01&rft.issn=1930-7381&rft.eissn=1930-739X&rft.volume=21&rft.issue=9&rft.spage=1843&rft.epage=1849&rft_id=info:doi/10.1002%2Foby.20329&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_oby_20329
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1930-7381&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1930-7381&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1930-7381&client=summon